Aktis Oncology Inc
NAS:AKTSHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG$15.60+3.24%LiveIn session · ≈ AED 57.29 · Market cap $867.66M · Next earnings Thu 12 Nov
| USD millions | FY2022 | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|---|
| Net income | (17.9) | (28.6) | (44.0) | (63.7) | −44.9% | |
| Depreciation & amortization | 0.4 | 1.1 | 1.6 | 2.3 | +47.9% | |
| Stock-based compensation | 0.7 | 1.5 | 2.3 | 5.1 | +127.0% | |
| Change in working capital | (1.1) | (0.0) | 59.0 | (3.2) | −105.5% | |
| Operating cash flow | (18.1) | (30.0) | 14.8 | (64.1) | −534.4% | |
| Capital expenditure | (2.3) | (3.8) | (2.9) | (9.6) | −234.9% | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Investing cash flow | (2.3) | (68.8) | (190.4) | 66.0 | +134.6% | |
| Dividends paid | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Share buybacks | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Debt issued / repaid | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Financing cash flow | 120.0 | 0.0 | 183.3 | (1.2) | −100.7% | |
| Free cash flow | (20.4) | (33.8) | 11.9 | (73.7) | −719.4% | |
| Net change in cash | 99.6 | (98.8) | 7.6 | 0.6 | −91.8% |
USD millionsUpdated Thu 13 Aug ·
ⓘ
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
